数位药局市场：按药物类型、平台划分 - 2025-2030 年全球预测

2023年数位药局市场规模为1,389.1亿美元，预计2024年将达1,649.1亿美元，复合年增长率为19.20%，2030年将达4,750.8亿美元。

数位药局市场包括透过数位方式促进药品和服务分销的线上平台。该市场包括电子处方、线上药物管理、数位咨询以及透过网路和行动应用程式提供的处方药交付服务。对数位药局不断增长的需求是由患者对便利性的偏好、改善获得广泛的医疗保健服务以及改善药物依从性管理所推动的，特别是随着慢性病的增加和人口老龄化的发生。应用范围从远端医疗咨询和与医疗保健系统的无缝整合到简化处方笺补充和用药历史管理。最终使用领域包括寻求提供更全面、更具成本效益的解决方案的个人消费者、医疗保健提供者和保险公司。

市场成长受到医疗保健 IT 技术进步、智慧型手机和网路普及率的提高以及促进电子医疗计划的支持性政府法规等因素的影响。 COVID-19 大流行透过加速数位医疗解决方案并解决传统医疗保健服务系统的差距，为新兴市场和服务不足的社区提供了持续成长的机会。然而，挑战也存在，包括资料隐私和安全问题、监管合规的复杂性以及来自老牌实体药局的竞争。此外，付款人和医疗保健提供者可能会犹豫是否要全面转型，因为这可能会破坏现有的照护模式。

低收入地区的技术基础设施和数位素养差异等问题也阻碍了广泛采用。因此，数位药局市场的创新可能集中在改善网路安全措施、开拓用户友好的平台以及增强人工智慧主导的个人化服务，例如自动重新处方提醒和药物交互作用检查。此外，与高科技公司的跨境合作和伙伴关係可以释放进一步的进步。市场的本质是动态的，新参与企业突破传统界限，提供客製化的、以患者为中心的服务，对现有企业提出挑战，同时承诺扩充性和改善的医疗保健结果，因此，可能会发生重大破坏。

市场动态：揭示快速发展的数位药局市场的关键市场洞察

供需的动态交互作用正在改变数位药局市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

• 市场驱动因素
  • 消费者越来越偏好在线上购买药品
  • 政府不断加强数位化倡议
  • 需要监控不断扩大的数位疗法和患者特定资料的可用性
• 市场限制因素
  • 患者依赖线下药师进行临床支持
• 市场机会
  • 扩大远端保健和远端医疗的采用
  • 智慧镜科技与居家医疗诊断工具的整合与融合
• 市场挑战
  • 安全问题和非法网路药局的存在

波特五力：驾驭数位药局市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解数位药局市场的外部影响

外部宏观环境因素在塑造数位药局市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解数位药局市场的竞争状况

数位药局市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 数位药局市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估数位药局市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了数位药房市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，数位药房市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 消费者在网路上购买药品的偏好增加
    • 政府加大数位化力度
    • 需要监控不断增长的数位疗法和患者特定资料的可用性
  • 抑制因素
    • 患者依赖离线药师提供临床支持
  • 机会
    • 扩大远端医疗引进和远距医疗
    • 智慧镜子技术与家庭健康筛检工具的整合与嵌入
  • 任务
    • 对安全和非法网上药局存在的担忧
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章按药物类型分類的数位药局市场

• 非处方药
• 处方药

第七章数位药局市场：依平台

• 应用程式
• 网站

第八章美洲数位药局市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太地区数位药局市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章欧洲、中东和非洲的数位药局市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• AdhereHealth, LLC
• Amazon.com, Inc.
• Apollo Pharmacies Limited
• Costco Wholesale Corporation
• Digital Pharmacist, Inc.
• Giant Eagle Inc.
• GoodRx, Inc.
• Healthwarehouse,.Inc
• Hims & Hers Health, Inc.
• Optum, Inc.
• Pharmex Direct Inc.
• Rite Aid Corporation
• The Kroger Co.
• Walgreen Co.
• Walmart Inc.

The Digital Pharmacy Market was valued at USD 138.91 billion in 2023, expected to reach USD 164.91 billion in 2024, and is projected to grow at a CAGR of 19.20%, to USD 475.08 billion by 2030.

The digital pharmacy market encompasses online platforms that facilitate the distribution of pharmaceutical products and services through digital means. This market includes e-prescribing, online medication management, digital consultations, and delivery services of prescribed medicines via web and mobile applications. The growing necessity for digital pharmacies stems from the increasing patient preference for convenience, enhanced accessibility to a broader range of healthcare services, and improved management of medication adherence, especially amid the rise of chronic diseases and the aging population. Its application ranges from telehealth consultations and seamless integration with healthcare systems to streamlining prescription refills and medication history management. End-use sectors span individual consumers, healthcare providers, and insurance companies looking to offer more comprehensive and cost-effective solutions.

Market growth is influenced by factors such as technological advancements in health IT, increasing smartphone and internet penetration, and supportive government regulations promoting e-health initiatives. The COVID-19 pandemic accelerated the adoption of digital health solutions, presenting persistent growth opportunities in emerging markets and underserved communities by addressing gaps in traditional healthcare delivery systems. However, challenges exist, including concerns over data privacy and security, regulatory compliance complexities, and competition from well-established brick-and-mortar pharmacies. Payers and providers may also hesitate to transition fully due to potential disruptions in existing care models.

Limitations revolve around technology infrastructure in low-income regions and the digital literacy divide that may hinder widespread adoption. Consequently, innovation within the digital pharmacy market can focus on improving cybersecurity measures, developing user-friendly platforms, and enhancing artificial intelligence driven personalization in services, such as automatic refill reminders or medication interaction checks. Moreover, cross-border collaborations and partnerships with tech firms could unlock further advancements. The market's nature is dynamic, with potential for substantial disruption as new entrants arrive, pushing traditional borders and offering tailored, patient-centric services that challenge incumbents while promising scalability and improved healthcare outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Pharmacy Market

The Digital Pharmacy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing consumer preference towards buying medicines online
  • Rising government initiatives towards digitalization
  • Need to monitor growing availability of digital therapeutics and patient-specific data
• Market Restraints
  • Patients reliance on offline pharmacists for clinical support
• Market Opportunities
  • Growing adoption of telehealth and telemedicine
  • Integration and incorporation of smart mirrors technology and home health diagnostic tools
• Market Challenges
  • Concerns related to security and presence of illegal online pharmacies

Porter's Five Forces: A Strategic Tool for Navigating the Digital Pharmacy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Pharmacy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Pharmacy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Pharmacy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Pharmacy Market

A detailed market share analysis in the Digital Pharmacy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Pharmacy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Pharmacy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Pharmacy Market

A strategic analysis of the Digital Pharmacy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Pharmacy Market, highlighting leading vendors and their innovative profiles. These include AdhereHealth, LLC, Amazon.com, Inc., Apollo Pharmacies Limited, Costco Wholesale Corporation, Digital Pharmacist, Inc., Giant Eagle Inc., GoodRx, Inc., Healthwarehouse,.Inc, Hims & Hers Health, Inc., Optum, Inc., Pharmex Direct Inc., Rite Aid Corporation, The Kroger Co., Walgreen Co., and Walmart Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Pharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Over-The-Counter Drugs and Prescription Drugs.
• Based on Platform, market is studied across Apps and Websites.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing consumer preference towards buying medicines online
    • 5.1.1.2. Rising government initiatives towards digitalization
    • 5.1.1.3. Need to monitor growing availability of digital therapeutics and patient-specific data
  • 5.1.2. Restraints
    • 5.1.2.1. Patients reliance on offline pharmacists for clinical support
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of telehealth and telemedicine
    • 5.1.3.2. Integration and incorporation of smart mirrors technology and home health diagnostic tools
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to security and presence of illegal online pharmacies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Digital Pharmacy Market, by Drug Type

• 6.1. Introduction
• 6.2. Over-The-Counter Drugs
• 6.3. Prescription Drugs

7. Digital Pharmacy Market, by Platform

• 7.1. Introduction
• 7.2. Apps
• 7.3. Websites

8. Americas Digital Pharmacy Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Digital Pharmacy Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Digital Pharmacy Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AdhereHealth, LLC
• 2. Amazon.com, Inc.
• 3. Apollo Pharmacies Limited
• 4. Costco Wholesale Corporation
• 5. Digital Pharmacist, Inc.
• 6. Giant Eagle Inc.
• 7. GoodRx, Inc.
• 8. Healthwarehouse,.Inc
• 9. Hims & Hers Health, Inc.
• 10. Optum, Inc.
• 11. Pharmex Direct Inc.
• 12. Rite Aid Corporation
• 13. The Kroger Co.
• 14. Walgreen Co.
• 15. Walmart Inc.

LIST OF FIGURES

• FIGURE 1. DIGITAL PHARMACY MARKET RESEARCH PROCESS
• FIGURE 2. DIGITAL PHARMACY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIGITAL PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DIGITAL PHARMACY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DIGITAL PHARMACY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIGITAL PHARMACY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIGITAL PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIGITAL PHARMACY MARKET DYNAMICS
• TABLE 7. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY APPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIGITAL PHARMACY MARKET SIZE, BY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 20. CANADA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 32. CHINA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 34. INDIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 69. ITALY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 77. POLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 79. QATAR DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 99. DIGITAL PHARMACY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. DIGITAL PHARMACY MARKET, FPNV POSITIONING MATRIX, 2023